There may be a new way to prevent breast cancer in post-menopausal women who are at high risk.
Tamoxifen is already used, but researchers have discovered that Raloxifene works just as well, and has fewer side effects.
Currently, Raloxifene is prescribed for osteoporosis.
Twenty thousand women were given the drug in a study sponsored by the U-S National Cancer Society.
